<DOC>
	<DOCNO>NCT01846689</DOCNO>
	<brief_summary>The objective study measure change blood value administration amino acid base erythropoietin stimulating system .</brief_summary>
	<brief_title>An Open-label Trial Determine Increased Red Blood Cell Production Subjects With Anemia Chronic Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . M/F patient 18 year old , nonpregnant/lactating 2 . Hemoglobin &lt; 10 female , &lt; 11 male 3 . Ferritin &gt; upper limit normal lab indicative chronic anemia 4 . Anemia chronic disease 5 . Crt . &lt; 3.0 1 . Currently take amino acid formulation . 2 . Pregnant unwilling use adequate birth control duration study . 3 . Excessive alcohol illicit drug use . 4 . Unwilling unable sign inform consent . 5 . Myocardial infarction within last 6 month . 6 . Patients ever take currently take erythropoietin medication . 7 . Iron deficiency ( add criterion ) . 8 . On dialysis . 9 . Malignancy nonmelanoma skin cancer within last 5 year . If malignancy , must documentation recurrence least 5 year . 10 . Liver cirrhosis ( add criterion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>